If you missed out on the enormous run in biotechnology stocks this past year, Hillary Clinton just gave you a second chance.
Take it.
Since Clinton’s infamous Sept. 21 tweet attacking drug companies for “price gouging,” biotech investors have lost an astonishing $132 billion. I’m pretty sure I know what they think of Hillary.
Hey, check out all the research scientist jobs. Post your resume today!
